SEID PAUL purchased $834 of INLX

SEID PAUL purchased 162 shares of INTELLINETICS, INC. (INLX) at $5.15 on 2026-10-01.

Original reporting
SEC EDGAR · SEID PAUL
Published Oct 5, 2026, 9:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$INLX
Bullish
medium confidence
Mentioned
$INLX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INLXBullishLow
01

Why it matters

The director's purchase may be interpreted as a vote of confidence, but the dollar amount is modest.

02

Market read

Small insider buy; limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed may motivate the buy.

Relevance 4/10Novelty 4/10Timing: post-market 2026-10-05

Background

Form 4 filings disclose insider transactions; this filing reports a director's purchase.

Company-level read

Ticker impact

$INLXBullishMedium confidence
Context

Director Seid Paul bought 162 shares for $834, increasing his stake to 193,801 shares.

Expected impact

modest upward pressure as market prices in insider buying

Evidence & confidence

The purchase is small relative to market cap, but director-level buying is viewed positively.

Market effects

Minimal impact on the broader biotech sector.

No regional effect.

Limited to investors tracking insider activity.

Counterpoint

The purchase is too small to affect price; could be routine portfolio rebalancing.

Key entities

  • Intellinetics, Inc.

    Biotech firm whose director made the purchase.

  • Seid Paul

    Director of Intellinetics who bought shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INLXMed

Intellinetics Reports Second Quarter and Six-Month 2026 Results

INTELLINETICS, INC. (INLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Intellinetics Reports Second Quarter and Six-Month 2026 Results COLUMBUS, OH – August 12, 2026 – Intellinetics, Inc. ( NYSE American: INLX ), a digital transformation solutions provider, announced financial results for the three and six months ended June 30, 2026. 20

$CTEVLow

ARES MANAGEMENT LLC purchased $2.9M of CTEV (indirect holdings)

ARES MANAGEMENT LLC purchased 115,579 indirectly-held shares of Claritev Corp (CTEV) at an average of $25.40 ($24.42–$26.14, $2.94M total) across 2 trades over 2026-11-09 to 2026-11-10. Filed jointly with ASOF Investment Management LLC (10% owner), Ares Management Holdings L.P. (10% owner), Ares Holdco LLC (10% owner), Ares Management Corp (10% owner), Ares Voting LLC (10% owner), Ares Management GP LLC (10% owner) and Ares Partners Holdco LLC (10% owner).